-
Mashup Score: 0JNCCN 360 - MM - Deep Dive Into Real-World Data on Daratumumab in Myeloma: Focus on Dosing Frequency - 1 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0JNCCN 360 - MM - Initial Trial Results With Novel Combination Therapy for Resistant Myeloma - 3 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0JNCCN 360 - MM - Comparing Triplet Regimens in Newly Diagnosed Myeloma: Is There a Clear Winner? - 5 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0JNCCN 360 - MM - Screening for MGUS in High-Risk Groups May Reduce Health Disparities in Myeloma - 6 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0JNCCN 360 - MM - More MagnetisMM-3 Results Support Elranatamab’s Potential in Myeloma - 6 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
Deep Dive Into Real-World Data on Daratumumab in #Myeloma: Focus on Dosing Frequency: https://t.co/UK0rEoas7K #JNCCN360 #mmsm https://t.co/GcrNHQNUOr